US Stock MarketDetailed Quotes

SHANGHAI FOSUN PHARMACEUTICAL GROUP (SFOSF)

Watchlist
  • 2.200
  • 0.0000.00%
15min DelayClose Aug 19 14:49 ET
5.87BMarket Cap11.28P/E (TTM)

SHANGHAI FOSUN PHARMACEUTICAL GROUP (SFOSF) Cash Flow

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: CNY
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
2022/Q3
2022/Q2
2022/Q1
2021/Q4
2021/Q3
2021/Q2
Net cash flow from investing
-834.29%-1.73B
+45.98%-633.93M
-410.17%-652.10M
+53.75%-674.65M
+84.46%-185.09M
-119.37%-1.17B
+122.80%210.24M
+34.43%-1.46B
-768.33%-1.19B
-486.22%-535.00M
+46.30%-922.27M
-119.09%-2.22B
+90.67%-137.18M
+110.89%138.52M
-1165.91%-1.72B
-16.05%-1.02B
+6.67%-1.47B
-13.39%-1.27B
+88.75%-135.66M
+25.53%-875.05M
Net PPE Purchase and Sale
+6.16%-1.05B
-6.52%-1.24B
-49.87%-1.05B
-14.95%-955.64M
+10.93%-1.12B
-4.19%-1.16B
+44.63%-703.54M
+32.89%-831.37M
+26.31%-1.25B
+22.69%-1.12B
+31.11%-1.27B
-18.56%-1.24B
-17.55%-1.70B
+1.61%-1.45B
-61.95%-1.84B
-5.09%-1.04B
-13.63%-1.45B
-26.28%-1.47B
+16.63%-1.14B
-14.24%-994.26M
Net Business Purchase and Sale
-23225.36%-231.25M
+122.09%49.25M
-154.55%-25.34M
+471.76%171.74M
-99.28%1.00M
-200.57%-222.89M
+213.18%46.45M
+95.63%-46.20M
+390.55%138.27M
+3714.43%221.62M
+94.35%-41.04M
-431.02%-1.06B
+35.84%-47.59M
+93.75%-6.13M
-375.90%-726.47M
+46.45%319.22M
-4138.74%-74.18M
+1.68%-98.09M
+918.67%263.31M
--217.97M
Net Investment Purchase and Sale
-118.39%-201.08M
+226.48%753.03M
-57.16%336.21M
+125.27%122.31M
+805.17%1.09B
-66.94%230.65M
+1.80%784.86M
-306.79%-483.99M
-76.62%120.82M
-43.27%697.60M
-21.84%770.96M
-243.19%-118.98M
-39.14%516.77M
+629.97%1.23B
+70.16%986.34M
+242.38%83.09M
+128.62%849.15M
-157.57%-232.03M
+35.72%579.66M
+108.28%24.27M
Net Other Investing Changes
-52.63%-249.40M
-1041.57%-196.07M
+10.90%91.45M
+86.58%-13.05M
+17.03%-163.40M
+94.90%-17.18M
+121.62%82.47M
-151.30%-97.26M
-117.99%-196.94M
-193.48%-336.84M
-187.71%-381.46M
+150.82%189.57M
+237.19%1.09B
-31.63%360.35M
-182.66%-132.58M
-203.20%-373.00M
-18.90%-797.79M
+301.34%527.06M
+168.49%160.39M
-3787.72%-123.02M
Financing Cash Flow
+301.73%1.28B
+100.07%337.11K
-12.01%-1.78B
-183.33%-826.57M
-742.38%-633.63M
+46.76%-500.30M
+11.34%-1.59B
-11.27%991.93M
-65.02%98.64M
-72.55%-939.67M
-170.95%-1.80B
+25.92%1.12B
-81.85%281.97M
-628.88%-544.59M
+267.20%2.53B
+304.92%887.81M
+29.13%1.55B
-104.87%-74.72M
-69.60%-1.51B
-373.14%-433.25M
Net Issuance Payments Of Debt
+2001.90%1.50B
-89.97%47.31M
-43.87%-298.27M
+144.21%94.23M
-122.02%-79.04M
+199.60%471.83M
+30.66%-207.32M
-109.81%-213.12M
-42.98%358.93M
-101.27%-473.73M
+69.09%-298.97M
-7.14%2.17B
-75.88%629.52M
-154.49%-235.37M
-609.98%-967.23M
+17975.80%2.34B
+70.79%2.61B
+130.65%431.91M
-108.34%-136.23M
-103.15%-13.09M
Cash Dividends Paid
+19.70%-242.36M
+34.44%-235.95M
-7.35%-1.11B
+11.21%-295.90M
+8.92%-301.82M
+0.55%-359.92M
+29.51%-1.03B
-11.01%-333.24M
-1.97%-331.38M
-38.61%-361.91M
-345.12%-1.47B
+80.67%-300.18M
-40.76%-324.98M
-42.70%-261.10M
+74.85%-329.82M
-1087.81%-1.55B
+20.07%-230.88M
+20.99%-182.97M
-14.32%-1.31B
+0.00%-130.71M
Net Other Financing Charges
+110.38%24.94M
+136.78%207.76M
-13.97%-203.26M
-126.79%-457.22M
-384.09%-240.27M
-541.56%-564.86M
-7601.83%-178.35M
+384.99%1.71B
+489.56%84.58M
-101.37%-88.05M
-99.94%2.38M
-442.08%-598.89M
+97.37%-21.71M
+70.53%-43.72M
+20533.76%3.89B
+175.25%175.07M
-3309.22%-825.81M
-104.65%-148.39M
+98.45%-19.05M
-1926.22%-232.67M
Ending Cash Balance
-0.63%9.58B
-3.76%9.04B
-16.26%7.94B
-6.61%9.22B
+3.07%9.64B
-1.17%9.39B
-6.00%9.48B
-18.18%9.87B
-22.85%9.35B
-14.93%9.50B
-5.71%10.08B
+45.60%12.06B
+64.87%12.12B
+72.92%11.17B
+54.20%10.69B
+14.27%8.28B
-4.74%7.35B
-11.81%6.46B
-0.28%6.93B
-11.36%7.25B
Net Change in Cash
+194.36%697.51M
+752.56%1.20B
-292.28%-1.19B
-180.89%-422.90M
+235.27%236.96M
+64.84%-183.56M
+85.34%-302.98M
+407.26%522.80M
-117.21%-175.18M
-178.18%-522.09M
-195.71%-2.07B
-120.87%-170.15M
+8.40%1.02B
+257.21%667.77M
+733.56%2.16B
+340.94%815.38M
+157.33%939.19M
-178.93%-424.77M
+69.19%-340.88M
-642.17%-338.42M
Beginning Cash Balance
-3.76%9.04B
-16.26%7.94B
-6.61%9.22B
+3.07%9.64B
-1.17%9.39B
-6.00%9.48B
-18.18%9.87B
-22.85%9.35B
-14.93%9.50B
-5.71%10.08B
+45.60%12.06B
+64.87%12.12B
+72.92%11.17B
+54.20%10.69B
+14.27%8.28B
-4.74%7.35B
-11.81%6.46B
-0.28%6.93B
-11.36%7.25B
-4.99%7.72B
Effect of Exchange Rate Changes
-1879.23%-158.57M
-198.32%-95.98M
-4.40%-90.59M
+113.48%850.22K
-61.97%8.91M
+269.24%97.63M
-196.50%-86.77M
-105.80%-6.31M
+134.79%23.44M
+69.80%-57.68M
-64.21%89.91M
-5.48%108.78M
-43.31%-67.37M
-224.42%-190.98M
+816.11%251.24M
+187.50%115.08M
-266.37%-47.01M
+64.80%-58.87M
+123.56%27.42M
-1412.78%-131.52M
Free Cash Flow
+190.97%57.23M
+414.97%551.55M
+4.86%153.13M
-18.42%123.01M
+81.34%-62.92M
+164.28%107.10M
+123.43%146.04M
+149.81%150.79M
+59.37%-337.14M
+50.83%-166.63M
-16.37%-623.30M
-97.43%-302.70M
-28.98%-829.86M
+38.29%-338.90M
-671.95%-535.64M
-274.62%-153.31M
-19.48%-643.42M
+47.14%-549.21M
+124.94%93.65M
-119.97%-40.92M
Deadline
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Accounting Standard
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
2026/Q12025/Q42025/Q32025/Q22025/Q12024/Q42024/Q32024/Q22024/Q12023/Q42023/Q32023/Q22023/Q12022/Q42022/Q32022/Q22022/Q12021/Q42021/Q32021/Q2
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On August 24 (U.S. Eastern Time), U.S. Treasury Secretary Bessent announced "unprecedented" economic actions against Iran, aiming to sever i Show More